In Vivo Radioligand Therapy Scientist – Preclinical

DTX Pharma, a Novartis Company; Basel; Vor Ort; CHF 76.000 - 142.000; Vollzeit

Benefits dieser Stelle

Hybrid working options

14 weeks parental leave

Insurance & retirement plans

Zusammenfassung

DTX Pharma, a Novartis Company, Basel, is seeking a Research Scientist for preclinical Radioligand Therapy to develop and characterize in vivo oncology models and evaluate new radioligand treatments. You will work with rodents, pharmacology, bioanalysis, and imaging to inform translational decisions and support our oncology portfolio.

You will collaborate across global teams, perform PET/SPECT/CT imaging studies, and contribute to in vitro and ex vivo assays such as PCR, Western blotting, and

Qualifikationen

• Bachelor's or Master's degree in Cell Biology, Medical Physics, Bioengineering, Biotechnology, Pharmacology, or related field.
• Hands-on experience with rodent handling and in vivo oncology models, including dosing, sampling, and animal welfare requirements.
• Practical in vivo experience gained within an academic or industry biomedical research laboratory.
• Training and practical experience working safely with open radioactive sources.
• Advanced written and spoken English, with the ability to communicate scientific findings effectively.

Aufgaben

• Develop and characterize novel in vivo oncology models to support preclinical radioligand therapy research.
• Conduct efficacy studies evaluating novel radioligand therapies across oncology programs.
• Perform biodistribution studies and metabolite analyses to inform pharmacology decisions.
• Conduct small-animal PET, SPECT, and CT imaging studies.
• Support in vitro and ex vivo activities, including cell culture, flow cytometry, immunohistochemistry, immunofluorescence, autoradiography, PCR, and Western blotting.

Kenntnisse

In vivo oncology models

Rodent handling

Imaging techniques

Bioanalysis

English communication

Ausbildung

Bachelor's or Master's in relevant field

Tools

PET/SPECT/CT imaging

PCR/Western blotting

Immunohistochemistry

Radioactive handling

Jobbeschreibung

DTX Pharma, a Novartis Company, Basel, is seeking a Research Scientist for preclinical Radioligand Therapy to develop and characterize in vivo oncology models and evaluate new radioligand treatments. You will work with rodents, pharmacology, bioanalysis, and imaging to inform translational decisions and support our oncology portfolio.

You will collaborate across global teams, perform PET/SPECT/CT imaging studies, and contribute to in vitro and ex vivo assays such as PCR, Western blotting, and